The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
LEONARDA-1: Phase III randomized study of lerociclib plus fulvestrant in patients with HR+, HER2- locally advanced or metastatic breast cancer that has progressed on prior endocrine therapy.
 
Binghe Xu
Speakers' Bureau - AstraZeneca; Eisai; Pfizer; Roche
Research Funding - Jiangsu Hengrui Medicine (Inst)
 
Qingyuan Zhang
No Relationships to Disclose
 
Yang Luo
No Relationships to Disclose
 
Zhongsheng Tong
No Relationships to Disclose
 
Tao Sun
No Relationships to Disclose
 
Changping Shan
No Relationships to Disclose
 
Xinlan Liu
No Relationships to Disclose
 
Yumin Yao
No Relationships to Disclose
 
Bing Zhao
No Relationships to Disclose
 
Shusen Wang
No Relationships to Disclose
 
Xiaohua Zeng
No Relationships to Disclose
 
Changlu Hu
No Relationships to Disclose
 
Xi Yan
No Relationships to Disclose
 
Xiaojia Wang
No Relationships to Disclose
 
Hongyan Jia
No Relationships to Disclose
 
Zhendong Chen
No Relationships to Disclose
 
Fuming Qiu
No Relationships to Disclose
 
Xinhong Wu
No Relationships to Disclose
 
Deyong Zhang
Employment - Genor BioPharma
Stock and Other Ownership Interests - Genor BioPharma
 
Tong Li
Employment - Genor BioPharma
Stock and Other Ownership Interests - Genor BioPharma